Investigating the optimal size of anticancer nanomedicine

Nanomedicines (NMs) offer new solutions for cancer diagnosis and therapy. However, extension of progression-free interval and overall survival time achieved by Food and Drug Administration-approved NMs remain modest. To develop next generation NMs to achieve superior anticancer activities, it is cru...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tang, Li, Yang, Xujuan, Yin, Qian, Cai, Kaimin, Wang, Hua, Chaudhury, Isthier, Yao, Catherine, Zhou, Qin, Kwon, Mincheol, Hartman, James A., Dobrucki, Iwona T., Dobrucki, Lawrence W., Borst, Luke B., Lezmi, Stéphane, Helferich, William G., Ferguson, Andrew L., Fan, Timothy M., Cheng, Jianjun
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2014
Matèries:
Physical Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217425/
https://ncbi.nlm.nih.gov/pubmed/25316794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1411499111
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars